Anti-Fox2 / RBM9 antibody [4G3]
4
(3 Reviews)
|
(20 Publications)
Mouse Monoclonal Fox2 / RBM9 antibody. Suitable for Flow Cyt, WB, IHC-P, ICC/IF and reacts with Human, Mouse samples. Cited in 20 publications. Immunogen corresponding to Recombinant Fragment Protein within Human RBFOX2 aa 1-100.
View Alternative Names
FOX2, HRNBP2, RBM9, RTA, RBFOX2, RNA binding protein fox-1 homolog 2, Fox-1 homolog B, Hexaribonucleotide-binding protein 2, RNA-binding motif protein 9, RNA-binding protein 9, Repressor of tamoxifen transcriptional activity
- Flow Cyt
Unknown
Flow Cytometry - Anti-Fox2 / RBM9 antibody [4G3] (AB57154)
Overlay histogram showing HeLa cells stained with ab57154 (red line). The cells were fixed with 4% paraformaldehyde (10 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab57154, 1μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG2a [ICIGG2A] (ab91361, 1μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in HeLa cells fixed with 80% methanol (5 min)/permeabilized with 0.1% PBS-Tween for 20 min used under the same conditions.
This image was generated using the ascites version of the product.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Fox2 / RBM9 antibody [4G3] (AB57154)
ICC/IF image of ab57154 stained SHSY5Y cells. The cells were 4% formaldehyde fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab57154, 1μg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-mouse IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43μM.
This image was generated using the ascites version of the product.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Fox2 / RBM9 antibody [4G3] (AB57154)
Fox2 / RBM9 antibody (ab57154) used in immunohistochemistry at 3ug/ml on formalin fixed and paraffin embedded human placenta.
This image was generated using the ascites version of the product.
- WB
Unknown
Western blot - Anti-Fox2 / RBM9 antibody [4G3] (AB57154)
Fox2 / RBM9 antibody (ab57154) at 1ug/lane + NIH/3T3 cell lysate at 25ug/lane.
This image was generated using the ascites version of the product.
All lanes:
Western blot - Anti-Fox2 / RBM9 antibody [4G3] (ab57154)
Predicted band size: 41 kDa
false
Reactivity data
Product details
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
RBM9 (Fox2) contributes to gene expression by influencing the splicing of pre-mRNA. It forms part of complex networks with other splicing-related proteins such as hnRNPs and SR proteins. Its function in alternative splicing impacts the diversity of protein isoforms which is important for cellular processes. This ability to modify gene expression patterns enables cellular adaptation to different physiological conditions.
Pathways
RBM9 interacts with key signaling cascades like PI3K/AKT and MAPK pathways. The protein aids in the regulation of genes involved in these pathways which are essential for cell growth and survival. RBM9 partners with other proteins such as AKT and ERK in these pathways facilitating their roles in cellular signaling. Its regulation of alternative splicing influences pathway outcomes contributing to normal and disease states.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (20)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 16:6861 PubMed40715150
2025
Applications
Unspecified application
Species
Unspecified reactive species
Biology direct 19:75 PubMed39198845
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature methods 20:1887-1899 PubMed37857907
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature cell biology 25:1359-1368 PubMed37640841
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports. Medicine 4:100962 PubMed36889320
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nucleic acids research 50:2270-2286 PubMed35137168
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 37:109910 PubMed34731606
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 25:8352-8362 PubMed34302435
2021
Applications
Unspecified application
Species
Unspecified reactive species
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 8:e2004852 PubMed34180133
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cancer biology & therapy 22:311-323 PubMed33879018
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com